TAK-653 vs Dihexa
Side-by-side comparison of TAK-653 and Dihexa: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
TAK-653
Dihexa
TAK-653
TAK-653 is a novel positive allosteric modulator (PAM) of AMPA-type glutamate receptors developed by Takeda Pharmaceuticals. It enhances glutamatergic neurotransmission without directly activating the receptor, offering…
Lowest listed price: $79.99 across 1 listing
Full TAK-653 profileDihexa
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. It is considered one of the most potent cognitive enhancers ever tested in animal models…
Lowest listed price: $79.99 across 3 listings
Full Dihexa profileSide-by-side comparison
| Attribute | TAK-653 | Dihexa |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Phase II Clinical Trials | Preclinical |
| Mechanism of Action | TAK-653 acts as a positive allosteric modulator (PAM) of AMPA receptors, binding to a site distinct from the glutamate binding site. It increases the receptor's sensitivity to glutamate, improving excitatory postsynaptic currents (EPSCs) and promoting… | Dihexa is a small-molecule analog derived from angiotensin IV (AngIV). It retains the Tyr-Ile core of Nle1-AngIV, with an N-terminal hexanoic acid cap and a C-terminal 6-aminohexanoic amide that give it metabolic stability and blood-brain-barrier penetration.… |
| Half-Life | 6-10 hours (estimated) | Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence. |
| Typical Dose Range | 0.1 mg - 6 mg | 5 to 40 mg oral per day (anecdotal range; no established human dose) |
| Dosing Frequency | Once daily | Once daily (oral), typically in the morning |
| Administration | Oral | Oral, Intranasal, Subcutaneous |
| Side Effects | Headache, mild nausea, insomnia (if taken late in day), potential overstimulation at higher doses. Seizure risk at supratherapeutic doses due to glutamatergic mechanism. Mild anxiety or agitation reported in some users. | No controlled human safety data. Anecdotal user reports include headache, fatigue, irritability or anxiety, insomnia, and vivid dreams, usually at higher doses. The most serious concern is theoretical rather than reported: because dihexa acts on the HGF/c-Met… |
| Molecular Weight | 282.27 | 504.7 g/mol |
| Common Vial Sizes | — | 50mg, 100mg |
Price tracking
Price History
2 data pointsTAK-653: potential benefits
- Cognitive enhancement and improved learning
- Antidepressant effects (treatment-resistant depression)
- Enhanced synaptic plasticity and LTP
- Increased BDNF expression
- Improved working memory and executive function
- Potential neuroprotective properties
Dihexa: potential benefits
- Synaptogenesis: formation of new dendritic spines and functional synapses (preclinical)
- Memory and spatial-learning support in rodent models
- Potential research application in Alzheimer's and other neurodegenerative disease models
- HGF/c-Met and PI3K/Akt-linked neuroplasticity (mechanism proposed; key paper retracted)
Frequently asked
What's the difference between TAK-653 and Dihexa?
TAK-653 is a nootropics that tak-653 acts as a positive allosteric modulator (pam) of ampa receptors, binding to a site distinct from the glutamate binding site. it increases the receptor's sensitivity to…. Dihexa is a nootropics that dihexa is a small-molecule analog derived from angiotensin iv (angiv). it retains the tyr-ile core of nle1-angiv, with an n-terminal hexanoic acid cap and a c-terminal…. The two differ in mechanism, half-life (6-10 hours (estimated) vs Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence.), and typical dose range.
Which has the longer half-life, TAK-653 or Dihexa?
TAK-653 has a half-life of 6-10 hours (estimated). Dihexa has a half-life of Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, TAK-653 or Dihexa?
Lowest listed price on BodyHackGuide: TAK-653 from $79.99, Dihexa from $79.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack TAK-653 and Dihexa?
Few pairs of research compounds have been tested together in people, so for most pairs no trial shows whether combining them is safe or adds anything. Each compound's page lists its side effects and the interactions in our record, and the table on this page puts their side effects side by side.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy TAK-653 or Dihexa
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.